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The genome of influenza A viruses is composed of eight negative-strand RNA segments which contain short noncoding
regions at their 3* and 5* ends. The signals required for replication, transcription, and packaging of the viral RNAs are
thought to be located in these regions. The highly conserved noncoding nucleotides, which form ‘‘panhandle’’ or ‘‘fork’’
structures by partial complementarity, are important for the transcriptional activity of the viral RNA polymerase. In contrast,
the nonconserved noncoding nucleotides located close to the open reading frame of the viral RNAs had not been implicated
in RNA transcription. Using a reverse-genetics system, we have now rescued influenza A/WSN/33 viruses whose NA-
specific RNA segments have deletions in these nonconserved noncoding regions. Deletion either of the nucleotide residues
between the poly(U) stretch and the stop codon at the 5* end or of the nucleotides between position 15 and the start codon
at the 3 * end did not affect the amount of NA-RNA species found in virions or infected cells. However, a combination of
deletions at both the 3 * and the 5* ends decreased by 60 times the levels of NA-specific viral RNA found in infected cells
at late periods of infection and in virions. This double deletion was also responsible for a fourfold reduction of the steady-
state levels of the NA-specific mRNA in infected cells. Viruses whose NA-specific open reading frames were flanked by
the noncoding regions of the PB1- or the NS-RNA segments of influenza A/WSN/33 virus also showed a reduction in the
NA-specific viral RNA in virions and in infected cells. The present results demonstrate that the nonconserved nucleotides
at the 3 * and 5* ends of the NA-RNA segment of influenza A virus play an important role in the replication of this segment.
q 1996 Academic Press, Inc.
INTRODUCTION which is formed as a result of the partial complementarity
between the 12 and 13 conserved nt at the 3 * and the
Influenza A viruses are negative-strand RNA viruses
5* ends of the vRNAs (Hsu et al., 1987). In addition, the
whose genome consists of eight different RNA segments.
panhandle may be extended by nonconserved nt at the
The genomic RNAs are found in virions and infected cells
3 * and 5* ends, sometimes even involving a portion of
together with the viral NP and P (PB1, PB2, and PA)
the U-stretch at the 5* end. Thus, nt 14, 15, and 16 at the
proteins as ribonucleoprotein (RNP) complexes. The viral
5* end of the vRNAs are in general complementary to nt
RNAs (vRNAs) contain one or more open reading frames
13, 14, and 15 at the 3 * end. These nt positions, although
(ORF) which are flanked by short noncoding sequences
nonconserved among the different vRNA segments, are
at both ends of the gene (for reviews see Lamb, 1989;
in most instances highly conserved for the same seg-
Lamb and Horvath, 1991). These noncoding sequences
ment of different influenza virus strains (Desselberger et
are believed to contain the signals required for the repli-
al., 1980; Stoeckle et al., 1987).
cation, transcription, and packaging of the vRNAs (Lu-
Once the viral RNPs enter the nucleus of the infected
ytjes et al., 1989). The noncoding sequences of the differ-
cell, transcription and replication of the viral genome is
ent RNA segments of all influenza A virus strains share
achieved by a viral-coded RNA-dependent RNA polymer-
several striking characteristics: (1) The first 12 and 13
ase. RNA replication takes place through replicative in-
nucleotides (nt) at the 3 * and 5* ends of the vRNAs,
termediate RNAs (cRNAs), which are full-length copies
respectively, are highly conserved among different RNA
of the vRNAs (for a review see Krug et al., 1989). The
segments and virus strains. (2) A stretch of 5–7 uridine
promoters for RNA synthesis are thought to be formed
residues is located 15–16 nt away from the 5* end. (3)
by the 12 and 13 conserved nt at the 3 * and 5* ends of
The U-stretch is juxtaposed to a panhandle structure
the vRNAs and cRNAs. Reverse genetics and in vitro
studies confirmed that the conserved nt at the 3 * end
1 To whom correspondence and reprint requests should be ad- are indeed part of the RNA promoter (Parvin et al., 1989;
dressed. Fax: (212) 534-1684; E-mail: Agarcia@smtplink.mssm.edu.
Yamanaka et al., 1991; Li and Palese, 1992; Seong and2 On leave of absence from the Department of Biochemistry and
Brownlee, 1992a,b; Piccone et al., 1993; Neumann andMolecular Biology, Faculty of Medicine, University of Salamanca, Sala-
manca, Spain. Hobom, 1995). However, the viral RNA polymerase binds
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preferentially to the conserved 5* end of the RNA (Fodor and A/PR/8/34 viruses, was supplied by Evans Biological,
Ltd., Liverpool, England.et al., 1994; Tiley et al., 1994) and it is now accepted that
a panhandle or fork RNA structure is needed for optimal
vRNA and cRNA promoter activity in vitro (Fodor et al., Construction of plasmids
1994, 1995; Pritlove et al., 1995).
The vRNAs are used as templates for the synthesis of pT3NAM1 contains the complete NA gene of WSN
virus flanked by the T3 RNA polymerase promoter andmRNAs and cRNAs. In contrast to cRNA formation, mRNA
synthesis terminates at the U-stretch of the vRNAs by BbsI restriction enzyme site (GarcıB a-Sastre et al., 1994).
Two silent nt changes were introduced into the NA-spe-addition of a poly(A) tail. The RNA polymerase is thought
to stutter at the U-stretch due to the panhandle structure cific cDNA creating a ClaI site at nt positions 52–57. For
the construction of pT3NA3D, a PCR product was madelocated next to the U-stretch. Accordingly, both the U-
stretch and the panhandle structure are needed for using pT3NAM1 as template and the following primers:
5*-GGCCATCGATCCAATGGTTATTATTTCTGGTTT-mRNA synthesis (Luo et al., 1991; Li and Palese, 1994).
Another difference between influenza cRNAs and mRNAs GGATTCATACTCCTGCTTTTGCTCGAAGAG-3 * and 5*-
GTTTTCCCAGTCACGAC-3 *. The PCR product was di-is that the latter are capped. Transcription of the mRNAs
is primed by short capped oligonucleotides which are gested with EcoRI and ClaI restriction enzymes and it
was cloned into pT3NAM1 cut with the same restrictionthought to be cleaved from cellular mRNAs by the PB2
protein, a subunit of the viral RNA polymerase. The 5* enzymes. Another PCR was performed in order to con-
struct the plasmids pT3NA5D and pT3NAdD, usingend of the vRNA stimulates the binding of the viral poly-
merase to capped mRNAs, but both 5* and 3 * ends of pT3NAM1 as template and two oligonucleotides 5*-GGC-
CAAGCTTTAAATTAACCCTCACTAAAAGTAGAAACA-the vRNA are needed for activation of the endonuclease
activity (Hagen et al., 1994; Cianci et al., 1995). AGGAGTTTTTTCTACTTGTCAATGGTG-3 * and 5*-TGG-
ACTAGTGGGAGCATCAT-3 * as primers. The PCRWhile the conserved features of the influenza virus
RNAs are known to be involved in polymerase binding, product was digested with SpeI and HindIII restric-
tion enzymes and cloned into SpeI/HindIII-digestedpromoter activity, polyadenylation, and endonuclease ac-
tivity, a function has not yet been determined for the pT3NAM1 or pT3NA3D.
pT7CASCAT contains the complete sequence of thenonconserved noncoding sequences which are located
between the panhandle structure and the start codon at CAT ORF flanked by the noncoding regions of the NS-
segment of WSN virus (N. Percy, unpublished). pT3NA/the 3 * end and between the poly(U) stretch and the stop
codon at the 5* end of the vRNAs. These sequences are NS was constructed as follows: first, in order to construct
pT3NA/3NS5NA, a PCR product was made usingof different length and nt composition among different
RNA segments and among different influenza virus pT7CASCAT as the template and the two oligonucleo-
tides, 5*-GGCCATCGATCCAATGGTTATTATTTTCTGGT-strains. One might have expected that these noncon-
served sequences would not play a role in the replication TTGGATTCATTATGTCTTTGTCACCC-3 * and 5*-TCCCA-
GTCACGACGT-3 *, as primers. This PCR product wascycle of the virus. In the present report we demonstrate,
using a reverse genetics approach (Enami et al., 1990), digested with EcoRI and ClaI restriction enzymes and
cloned into pT3NAM1 cut with EcoRI and ClaI. Then, athat a change in these nt can dramatically affect the
levels of vRNA and mRNA in infected cells, and that second PCR was done using pT3NAM1 as template and
two oligonucleotides, 5*-GGCCAAGCTTATTAACCCTCA-the presence of specific coding sequences in the NA-
specific RNA segment appears to have an effect on its CTAAAAGTAGAAACAAGGGTGTTTTTTATTATTACTTGT-
CAATGGTG-3 * and 5*-TGGACTAGTGGGAGCATCAT-3 *,RNA levels.
as the primers. The product was digested by HindIII and
SpeI restriction enzymes and cloned into pT3NA/MATERIALS AND METHODS
3NS5NA cut with HindIII and SpeI.
Viruses and cells
For the construction of pT3NA/PB1, two silent muta-
tions were introduced into pT3NAM1 at nt 1358 (T to C)WSN-HK virus, a reassortant influenza virus containing
seven genes from influenza A/WSN/33 virus (WSN) and and 1360 (G to C) of the NA-specific cDNA to create a
SacI site. pT3CAT/PB1 contains the complete sequencethe NA gene from influenza A/HK/8/68 virus, was grown
in 10-day-old embryonated chicken eggs. WSN virus and of the CAT ORF flanked by the noncoding regions of the
PB1-segment of WSN virus (M. Bergmann, unpublished).transfectant viruses were grown in Madin–Darby bovine
kidney (MDBK) cells in reinforced minimal essential me- Using this plasmid as template, a PCR product was made
with the following two primers: 5*-GGCCGAGCTCC-dium. MDBK cells were also used for transfection experi-
ments and for selection and plaque purification of res- CGTTCACCATTGACAAGTAGTGAATTTAGCTTGTCC-3 *
and 5*-GGAATTGTGAGCGGATAAC-3 *. This product wascued transfectant viruses. Sucrose-gradient-purified in-
fluenza X-31 virus, a reassortant of influenza A/HK/8/68 cut with SacI and HindIII restriction enzymes and cloned
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into the modified pT3NAM1 digested with SacI/HindIII to Growth curve of the transfectant viruses
construct pT3NA/3NA5PB1. A second PCR was done by
Confluent monolayers of MDBK cells in 35-mm dishesusing pT3CAT/PB1 as template and oligonucleotides 5*-
were infected with NA3D, NA5D, NAdD, NA/NS, or NA/GGCCATCGATCCAATGGTTATTATTTTCTGGTTTGGATT-
PB1 transfectant viruses at a multiplicity of infectionCATTCAAATGGTTTGCC-3 * and 5*-TCCCAGTCACGA-
(m.o.i.) of 0.001. At 12-hr intervals, supernatants wereCGT-3 * as primers. Then the PCR product was cut with
harvested and hemagglutination (HA) titers and plaqueEcoRI and ClaI restriction enzymes and cloned into
forming unit (PFU) titers were determined using chickenpT3NA/3NA5PB1 digested with EcoRI and ClaI.
erythrocytes or MDBK cells, respectively. WSN virus wasPresence of the desired 3 * and 5* noncoding se-
used as a wild-type virus control.quences in all these plasmids was confirmed by se-
quencing with a DNA sequencing kit (United States Bio-
RNA electrophoresis
chemical Corporation, Cleveland, OH).
vRNAs extracted from sucrose-gradient-purified influ-
enza viruses were electrophoresed on a 2.8% polyacryl-
Ribonucleoprotein transfection
amide gel containing 7.7 M urea at 150 V for 1 hr 50 min.
RNA molecules were visualized by silver staining, asThe influenza virus RNA polymerase and NP protein
described previously (Luo et al., 1992).complex was isolated from influenza X-31 virus as de-
scribed (Parvin et al., 1989). RNP transfection was per-
RNA primer extensionformed in MDBK cells according to Enami and Palese
(1991) using WSN-HK as helper virus. Rescued transfec- The vRNAs of the NA- and NS-segments of WSN virus
tant viruses were plaque purified three times in MDBK and the NA3D, NA5D, NAdD, NA/NS, and NA/PB1
cells covered with agar overlay media. transfectant viruses were quantitated by primer exten-
sion, as previously described (Luo et al., 1992). The NS-
specific primer, 5*-GGGAACAATTAGGTCAGAAGT-3 *, isSequence of the NA genes of transfectant viruses
complementary to the region between nt 695 and 715 of
the NS-specific vRNA. The NA-specific primer, 5*-GTG-Sequences at the 3 * ends of the NA genes of transfec-
GCAATAACTAATCGGTCA-3 *, is complementary to thetant viruses NA3D, NA5D, NAdD, NA/NS, and NA/PB1
region between nt 1151 and 1171 of the NA-vRNA. Onewere confirmed as follows: first, RNA extracted from viri-
hundred nanograms of RNA extracted from sucrose-puri-ons was 3 *-polyadenylated using poly(A) polymerase
fied viruses or 5 mg of total RNA isolated from infected(Gibco BRL, Gaithersburg, MD). Then, polyadenylated
MDBK cells was reverse transcribed in the presence ofRNA was reverse transcribed using the primer 5*-TCT-
3 1 105 cpm of the end-labeled NS- and NA-specificAGATTTTTTTTTTTTTTTTAGC-3 * and Superscript re-
primers. The extended products were analyzed on a 6%verse transcriptase (Gibco BRL). The cDNA was PCR
polyacrylamide gel containing 7 M urea. The amount ofamplified using the primers 5*-GCGCAAGCTTCTAGA-
product was quantitated by a phosphorimaging systemTTTTTTTTTTTTTT-3 * and 5*-GCGCAAGCTTTATTGAGA-
(Molecular Dynamics, CA). For the isolation of vRNA fromTTATATTTCC-3 *, the latter containing nt positions 115 –
infected cells, MDBK cells were infected with either WSN98 of the NA gene of WSN. The PCR product was di-
virus or transfectant viruses at an m.o.i. of 2 and har-gested with XbaI and HindIII restriction enzymes, ligated
vested at the indicated time points. Cells were lysed withinto XbaI/HindIII-digested pUC19, and sequenced with a
guanidinium isothiocyanate, and total RNA was purifiedDNA sequencing kit (United States Biochemical Corpora-
by cesium chloride ultracentrifugation, as previously de-tion). For the sequencing of the 5* end of the NA gene
scribed (Luo et al., 1992).of the transfectant viruses, a reverse transcription–PCR
product was obtained using the oligonucleotide 5*-TGG-
RNase protection assay
ACTAGTGGGAGCATCAT-3 * (complementary to nt posi-
tions 1280 to 1299 of the WSN NA gene) as reverse The NA- and NS-specific mRNAs in MDBK cells in-
transcription and first PCR primer, and the oligonucleo- fected by WSN virus or NA3D, NA5D, or NAdD transfec-
tide 5*-GCGCAAGCTTAGTAGAAACAAGG-3 * (which con- tant viruses were measured by RNase protection assay,
tains the last 13 nt at the 5* end of the influenza A virus as per the manufacturer’s instructions (Ambion, Inc., Aus-
vRNAs) as the second PCR primer. The PCR products tin, TX). Negative-sense RNA probes which hybridize to
were cut with SpeI and HindIII restriction enzymes, li- the NA- and NS-specific positive-sense RNAs were made
gated into XbaI/HindIII-digested pUC19, and sequenced. from plasmids deIT3NAv and pIBI30-NS, respectively
RNAs were isolated by phenol extraction from viruses (Luo et al., 1992). The NA-specific probe was 403 nt long
purified through a 30–60% sucrose gradient (Luo et al., and contained the last 313 nt of the NA-specific vRNA.
Thus, the probe has the potential to protect two frag-1992).
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ments of 313 and 298 nt corresponding to the NA-specific
cRNA and mRNA, respectively. The NS-specific probe
was 470 nt long and contained the last 425 nt of the
NS-specific vRNA. This probe was designed to protect
fragments of 425 and 409 nt corresponding to the NS-
specific cRNA and mRNA, respectively. NA- and NS-spe-
cific probes were labeled in the presence of 4 ml of
[a-32P]UTP (800 Ci/mmol; DuPont NEN, Boston, MA) as
previously described (Luo et al., 1992). Five micrograms
of total RNA isolated from virus-infected cells and 5 1
104 cpm of the negative-sense NA- and NS-specific
probes were incubated at 457 for 36 hr. The hybridization
mixture was then digested with RNases A and T1 at 377
for 30 min. The digested products were analyzed on a
6% polyacrylamide gel containing 7 M urea and quanti-
tated by a phosphorimaging system (Molecular Dynam-
ics). Since cRNA synthesis was found to be only 3 to 5%
of that of mRNA synthesis, we could only quantify the NA-
specific mRNA levels under the assay conditions (Luo et
al., 1992).
FIG. 1. Schematic representation of influenza virus NA-specific
vRNAs used in rescue experiments. All sequences are shown in a
Analysis of NA protein synthesis in infected cells (hypothetical) panhandle configuration. The start and stop codons of
the NA genes are underlined. The heavy lines represent the coding
MDBK cells grown in 35-mm dishes were infected with sequences (ORF) of the NA gene. (A) Wild-type sequence of the noncod-
ing regions of the NA gene of influenza A/WSN/33 virus is shown oneither WSN virus or the transfectant viruses at an m.o.i.
the top. Sequences of the noncoding regions of the NA3D, NA5D,of 2. At the indicated time points, the cells were labeled
and NAdD vRNAs used in transfection experiments are also shown.using medium containing 25 ml of [35S]cysteine (1027 Ci/
Nucleotides that were deleted are shown in italics in the wild-type
mmol; DuPont NEN) for 15 min. Cells were then lysed in sequence (top). D indicates deletions in the mutants. (B) Sequences
100 ml of 0.15 M NaCl, 20 mM Tris–HCl (pH 7.4) con- of the noncoding regions of the NA/NS- and NA/PB1-vRNAs. These
sequences correspond to the wild-type noncoding sequences of thetaining 1.5% n-octylglucoside and 1 mM CaCl2 (lysis
NS- and PB1-specific vRNAs of influenza A/WSN/33 virus.buffer) after being chased with fresh medium for 30 min.
Five microliters of cell extracts was used for immunopre-
cipitation with a mixture of monoclonal antibodies 10C9
tant viruses. After three plaque to plaque passagings ofand 3C8 (specific for WSN NA protein) or with mono-
the transfectant viruses, a single plaque was used forclonal antibody HT-103 (specific for WSN NP protein) as
amplification in MDBK cells. The resulting virus prepara-described (Percy et al., 1994). Immunoprecipitated pro-
tions were used for further analysis. The identity of theteins were analyzed on a sodium dodecyl sulfate–10%
transfectant viruses was confirmed by sequencing thepolyacrylamide gel and quantitated by a phosphorim-
3 * and 5* ends of their NA-RNA segments, as describedaging system (Molecular Dynamics).
under Materials and Methods. Sequences were identical
to those of the corresponding transfected genes.
RESULTS
NA-specific vRNA levels in purified NA3D, NA5D, andRescue of transfectant influenza A viruses NA3D,
NAdD transfectant virusesNA5D, and NAdD
We have engineered three WSN NA genes in which Viral RNA isolated from purified wild-type and transfec-
tant viruses was used for quantitation of the levels ofportions of the NA-specific noncoding regions were de-
leted (Fig. 1A). The NA3D (3 * deletion) gene lacks 4 nt the NA-specific vRNA segment in virions. One hundred
nanograms of RNA from sucrose-purified transfectant vi-(AAUU) at positions 16–19 of the 3 * end adjacent to the
start codon of the NA gene. Seven nucleotides between ruses was analyzed by PAGE, and a dramatic reduction
in the amount of NA-RNA in NAdD virions was observedthe poly(U) stretch and the stop codon (GAACAAA, posi-
tions 22–28 of the 5* end) are deleted in the NA5D (5* in the silver-stained polyacrylamide gel, but not in that
of the NA-RNA of NA3D and NA5D viruses (Fig. 2). NA-deletion) gene. The NAdD (double deletion) gene has a
combination of both deletions at the 3 * and 5* ends. RNP specific vRNA levels were quantified by primer extension
analysis using the NS gene as internal control. Levels oftransfection of the engineered NA genes into WSN-HK-
infected MDBK cells resulted in the rescue of transfec- the NA-vRNA segment in NAdD virions were approxi-
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annealing of the primers to cellular RNAs, since they
were also detected when the cellular extracts were made
1.5 hr postinfection (data not shown).
NA-specific mRNA levels in NA3D, NA5D, and NAdD
transfectant virus-infected cells
Since vRNA serves as the template for mRNA synthe-
sis, we measured the mRNA levels in MDBK cells in-
fected with the NA-deletion mutants. Cell monolayers
were infected with wild-type or transfectant viruses at an
m.o.i. of 2. Total RNA from infected cells was extracted
at 1.5, 3.0, 4.5, 6.0, and 7.5 hr postinfection. The amount
of NA-specific mRNA was then determined by RNaseFIG. 2. Polyacrylamide gel electrophoresis of RNAs extracted from
protection assay as described under Materials and Meth-purified WSN, NA3D, NA5D, and NAdD viruses. RNAs were separated
in a 2.8% polyacrylamide gel containing 7.7 M urea and visualized by ods. The NS-specific mRNA was used as internal control.
silver staining. RNAs that encode polymerase proteins (Ps), hemaggluti- Figure 4 shows the PAGE analysis of the RNase digested
nin (HA), nucleoprotein (NP), neuraminidase (NA), matrix proteins (M), products. Under the present conditions, the NA- and NS-and nonstructural proteins (NS) are indicated. 18S ribosomal RNA,
specific cRNA signals are too low to be detected or arewhich often appears in viral RNA preparations as contaminant cellular
obscured by the mRNA signals. NA-specific mRNA levelsRNA, is also indicated.
in NAdD virus-infected cells at the peak of expression
(4.5 hr) were approximately four times lower than those of
mately 60 times reduced compared to those of wild-type WSN virus when standardized versus NS-specific mRNA
virus (Fig. 3A). However, the amount of NA-vRNA in the levels. However, NA-specific mRNA levels of the single-
single deletion mutants NA3D and NA5D was similar to deletion mutants were similar to those of WSN.
that of wild-type WSN virus. It should be noted that the
NA-specific extention products in Fig. 3A are slightly
shorter for the NA5D and NAdD viruses, due to the dele-
tion of seven nt at the 5* end of the NA-vRNA. Weak
additional bands present in Fig. 3A may represent vRNA
degradation products and/or premature termination
products of the reverse-transcription reaction.
NA-specific vRNA levels in NA3D, NA5D, and NAdD
transfectant virus-infected cells
The lower representation of the NA-specific vRNA seg-
ment in purified NAdD viruses could result from a lower
replication of the segment in virus-infected cells or from
a defect in the packaging of the NA-vRNA into budding
viruses or both. In order to distinguish among these pos-
sibilities, we performed a primer extension analysis of
the NA-specific vRNA segment in infected cells (Fig. 3B).
MDBK cells were infected with wild-type or transfectant
viruses at an m.o.i. of 2, and total RNA was isolated at
different times postinfection. NA-vRNA levels in NAdD
virus-infected cells were about 5, 30, and 60 times lower
FIG. 3. Measurement of the NA-specific vRNA levels in purified WSN,than those of WSN virus-infected cells at 6, 7.5, and 9
NA3D, NA5D, and NAdD viruses and in infected cells. (A) RNAs were
hr postinfection, respectively. Those of single deletion extracted from purified viruses and subjected to primer extension, using
mutants NA3D and NA5D were similar to those of WSN primers specific for the NA- and NS-vRNAs. Extended products were
analyzed in a 6% polyacrylamide gel containing 7.7 M urea. (B) MDBKvirus. Thus, at late times of infection, the amounts of NA-
cells were infected with the indicated viruses at an m.o.i. of 2. TotalvRNA in NAdD virus-infected cells and in purified viruses
RNA was extracted from virus-infected cells at the indicated time pointsare comparable. The results indicate that the lower repre-
postinfection (p.i.) and subjected to primer extension, using primers
sentation of NA-vRNA in NAdD purified viruses correlates specific for the NA- and NS-vRNAs. Extended products were analyzed
with a lower efficiency in NA-vRNA replication. The addi- in a 6% polyacrylamide gel containing 7 M urea. Molecular weight
markers are indicated on the left.tional bands present in Fig. 3B represent nonspecific
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FIG. 4. NA-specific mRNA levels in WSN, NA3D, NA5D, and NAdD
virus-infected cells. MDBK cells were infected with the indicated vi-
ruses at an m.o.i. of 2. Total RNA was extracted from virus-infected FIG. 5. Characterization of the NA protein expression levels in NAdD
cells at the indicated time points postinfection (p.i.) and subjected to virus-infected cells. MDBK cells were infected with NAdD or WSN vi-
RNAse protection analysis, using NS- and NA-specific probes (minus ruses at an m.o.i of 2. Infected cells were subsequent pulsed with
sense). Protected fragments were analyzed in a 6% polyacrylamide gel [35S]cysteine for 15 min and chased for another 30 min, at the indicated
containing 7 M urea. Signals derived from NS1- and NA-specific mRNAs time points postinfection (p.i.). Cell extracts were immunoprecipitated
are indicated. A control using positive-sense in vitro-transcribed NS- with a mixture of NA-specifc monoclonal antibodies or with an NP-
and NA-RNAs (cRNA-like) is shown on the left. Molecular weight mark- specific monoclonal antibody. Immunoprecipitated products were ana-
ers are also indicated on the left. lyzed by SDS–polyacrylamide gel electrophoresis. Molecular weight
markers (MW) are indicated on the left.
NA expression in NAdD transfectant virus-infected
cells 6). WSN virus was also included in the assay as positive
control. The maximum PFU titer of NAdD virus was ap-In order to investigate if the reduction in NA-specific
proximately 2 logs lower than that of wild-type virus.mRNA levels correlated with a reduction in NA levels,
However, single deletion NA mutants were not signifi-we measured the expression of NA in NAdD virus-in-
cantly affected in multicycle infectious virus productionfected cells at different times postinfection. MDBK cells
compared to WSN virus. HA titers of the NAdD virus werewere infected with NAdD or WSN viruses at an m.o.i. of
reduced only twofold (data not shown), indicating that a2. Cells were then pulse labeled at 1.5, 3.0, 4.5, and 6.0
large percentage of NAdD viruses is not infectious. Thus,hr postinfection. After a 30-min chase, cell lysates were
the NAdD virus is, in this respect, phenotypically similarobtained and the amounts of NA were compared by im-
munoprecipitation using NA-specific monoclonal anti-
bodies. For control, the NP protein was also immunopre-
cipitated with an NP-specific antibody. Although the
amount of NP protein was similar in NAdD and WSN
virus-infected cells, the amount of NA protein was about
10 times lower in NAdD-infected cells when labeled at
both 4.5 and 6.0 hr postinfection (Fig. 5). A similar reduc-
tion in the amount of NA was found in purified NAdD
viruses compared to that of wild-type viruses (data not
shown). We think that the differences found between the
levels of expression of NA protein (10 times lower) and
NA-specific mRNA (4 times lower) in NAdD virus-infected
cells are not significant.
NAdD transfectant virus is attenuated in tissue
culture
FIG. 6. Growth curves of the transfectant influenza viruses NA3D,Growth properties of transfectant viruses NA3D, NA5D,
NA5D, and NAdD on MDBK cells. Confluent MDBK cells in 35-mmand NAdD were analyzed in MDBK cells. For this pur-
dishes were infected with influenza A/WSN/33 (WSN) virus or with the
pose, confluent MDBK cell monolayers were infected at transfectant NA3D, NA5D, or NAdD viruses at an m.o.i. of 0.001. At 12-
low m.o.i. (0.001) and virus production was assayed at hr intervals, infectious particles present in the media were titrated by
plaque assay in MDBK cells.different time points by plaque assay in MDBK cells (Fig.
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FIG. 7. Analysis of the transfectant viruses NA/NS and NA/PB1. (A) Characterization of the NA-specific vRNA levels in purified NA/NS and NA/
PB1 viruses. RNAs were extracted from purified viruses and subjected to primer extension, using primers specific for the NA- and NS-vRNAs.
Extended products were analyzed in a 6% polyacrylamide gel containing 7.7 M urea. (B) Characterization of the NA-specific vRNA levels in NA/NS
and NA/PB1 virus-infected cells. MDBK cells were infected with the indicated viruses at an m.o.i. of 2. Total RNA was extracted from virus-infected
cells at the indicated time points postinfection (p.i.) and subjected to primer extension, using primers specific for the NA- and NS-vRNAs. Extended
products were analyzed in a 6% polyacrylamide gel containing 7 M urea. Molecular weight markers are indicated on the left. (C) Growth curves of
the NA/NS and NA/PB1 viruses on MDBK cells. Confluent MDBK cells in 35-mm dishes were infected with influenza A/WSN/33 (WSN) virus or with
the transfectant NA/NS or NA/PB1 viruses at an m.o.i. of 0.001. At 12-hr intervals, infectious particles present in the media were titrated by plaque
assay in MDBK cells.
to the previously described NA/B-NS transfectant virus levels of NA/NS virus-infected cells were reduced by fac-
tors of 14, 40, and 50 at 6, 7.5, and 9.0 hr postinfection,(Muster et al., 1991; Luo et al., 1992). Both of these vi-
ruses have a low replication level of their NA gene when respectively, compared with WSN virus-infected cells. For
the NA/PB1 virus, these levels were reduced by factors ofcompared to that of wild-type WSN virus, resulting in a
large population of noninfectious viruses lacking the NA 4, 10, and 14 at 6, 7.5, and 9.0 hr postinfection, respectively.
These results indicate that the low representation of thegene. However, the NAdD virus is more drastically af-
fected by the introduced mutations than the NA/B-NS NA-specific vRNA in purified transfectant viruses corre-
lates with the respective levels of NA-specific vRNA invirus.
infected cells at late times. As expected, both NA/NS and
Rescue and characterization of transfectant viruses NA/PB1 transfectant viruses were attenuated in MDBK
containing NA-RNA segments whose noncoding cells (Fig. 7C).
sequences are derived from heterologous RNA
segments DISCUSSION
We have studied the contribution of the nonconservedWe have also engineered two WSN NA-RNA segments
in which the noncoding sequences at the 3* and 5* ends nt in the noncoding region of the NA-specific RNA seg-
ment of influenza A virus on influenza viral RNA replica-are substituted by the corresponding noncoding se-
quences of the PB1- and NS-RNA segments (Fig. 1B). RNP tion and transcription. For this purpose, we constructed
transfectant viruses in which we deleted nt positionstransfection of these two RNAs resulted in the rescue of the
transfectant viruses NA/NS and NA/PB1. The sequences of 16–19 at the 3* end of the NA-specific vRNA and/or nt
positions 22–28 at the 5* end. These nt are variablethe 3* and 5* ends of the NA-specific vRNAs isolated from
these viruses were identical to those of the transfected not only among different vRNA segments of the same
influenza virus strain, but also among NA-RNA segmentsRNAs. Primer extension analysis revealed that the NA-
specific vRNA levels in NA/NS and NA/PB1 transfectant of different influenza virus strains. In addition, a number
of in vitro transcription experiments have failed to provideviruses were about 50 and 5 times lower, respectively,
than those of wild-type WSN virus (Fig. 7A). As in the case evidence that these regions are important for transcrip-
tional activity. Thus, one might predict that deletion ofwith the NAdD virus, a significant reduction of the NA-
specific vRNAs was also found in NA/NS and NA/PB1 these nt would not affect virus replication. This is in fact
the case when a single deletion is made at either the 3 *virus-infected MDBK cells (Fig. 7B). The NA-specific vRNA
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or the 5* end of the NA-specific segment (viruses NA3D of more complex RNA structures, such as pseudoknots,
which might be required for interaction with cellular orand NA5D). These viruses are similar to wild-type virus
with respect both to their NA-specific vRNA and mRNA viral factors during RNA replication.
There are other explanations which could account forlevels and to their growth properties in tissue culture.
Single deletions also did not affect the packaging of the the lower NA-specific RNA levels in NAdD infected cells:
(1) The stability of NadD-specific vRNA or cRNA may beNA-specific vRNA segments into virions. However, when
both single deletions were combined in the same virus, lowered compared to that of the wild-type molecule. We
do not favor this hypothesis since it is unlikely that smallNAdD, we found that the level of the NA-specific vRNA
segment was dramatically reduced (60 times) in virions. deletions in the NA-specific RNA segment would affect
RNA stability in such a dramatic way. (2) It is possibleThis reduction does not seem to be due to a packaging
defect of the segment, since a similar reduction of the that the NP protein shows reduced binding activity to the
mutant NA-RNA. This would result in a lower rate ofNA-specific vRNA segment is found in virus-infected cells
at late times of infection. Also, the levels of NA-specific RNP formation, which is the actual template for RNA
transcription and replication. Since the NP shows non-mRNA—and subsequently of the NA protein—were re-
duced in virus-infected cells, although not to the same specific binding activity to single-stranded RNA (Albo et
al., 1995), the above-mentioned explanation does not ap-degree as the NA-specific vRNA. At 4.5 hr postinfection,
mRNA levels of the mutant gene were 4 times lower pear to be convincing. (3) The P proteins may have a
reduced binding activity to the mutant RNA. However,than wild-type levels. This difference between mRNA and
vRNA levels may indicate a preferential defect of the NA- the deleted nt in the NAdD-specific RNA segment do not
appear to be important for binding to the P proteins inspecific RNA synthesis at late times of infection. More
likely, the higher reduction in vRNA levels at 9 hr postin- vitro (Fodor et al., 1993, 1994; Tiley et al., 1994; Pritlove
et al., 1995). (4) The mutant NA-RNA could have a ten-fection is due to an intrinsic amplification effect during
the replication of the vRNA. Thus, since the expression dency to produce defective interfering (DI) RNAs by form-
ing internal deletions of the segment during RNA replica-levels depend on the amount of available template, one
would expect an exponential decrease of the amount of tion. We do not favor this possibility, since we did not
detect abnormally high levels of DI RNAs in our purifiedvRNA with time. For example, let us assume that a wild-
type virus quadruples the number of vRNA molecules NAdD virus preparations. (5) An intriguing possibility is
that the mutant NA-RNA is defective in antiterminationevery hour and that a mutant virus defective in replication
only doubles its number. In this case, starting with one activity. Antitermination is required in order to skip the
polyadenylation signal during the synthesis of cRNA fromNA-specific vRNA molecule, the wild-type virus will have
synthesized 4 molecules and the mutant virus only 2 vRNA. The presence of soluble NP seems to be required
for this activity (Beaton and Krug, 1986), but the cis-actingmolecules 1 hr later (twofold difference). However, 2 hr
later, the wild-type virus will have synthesized 16 mole- signals in the RNA responsible for this activity are not
known. A defect in antitermination activity would prefer-cules and the mutant virus only 4 molecules (fourfold
difference). entially affect the cRNA and vRNA levels, but the de-
crease of vRNA template would also result in lower levelsThere are several possible explanations for the pheno-
type of the NAdD transfectant virus. One possibility is of mRNA. Indeed, after several passages of the NAdD
virus in MDBK cells, there is in infected cells an accumu-that the NA-specific vRNA and/or cRNA has a reduced
promoter activity. In vitro experiments have confined the lation of vRNA molecules with an increased number of U
residues at the poly(U) stretch (unpublished). This findingregion of the promoter to the conserved nt at the 3 * and
5* ends (Yamanaka et al., 1991; Li and Palese, 1992; could indicate that the viral polymerase has a tendency
to stutter at the poly(U) stretch before copying the 5*Seong and Brownlee, 1992b; Piccone et al., 1993; Garcı´a-
Sastre and Palese, 1993). However, it is also known that end of the vRNA during cRNA synthesis. Again, it is not
obvious why changes at both the 3 * end and the 5* endthe panhandle/fork structure of the vRNA and cRNA plays
an important role in RNA promoter activity in vitro (Fodor are required to influence antitermination. Further molecu-
lar and biochemical studies will be needed in order toet al., 1994, 1995; Pritlove et al., 1995). Nucleotides close
to this structure may enhance or inhibit the formation of distinguish among these different explanations.
The characterization of the NAdD transfectant virusthe panhandle structure, either by directly interacting
with the conserved nt or by interacting with internal se- led us to the conclusion that the nonconserved nt located
at the 3 * and 5* noncoding ends play an important rolequences. In this respect, it is interesting to note that the
panhandle structure of the NAdD sequence is the least in the RNA replication. Deletion of these nt in the NA
gene results in an attenuated virus with low levels of NA-stable structure predicted by the method of Zuker (Zuker
and Stiegler, 1981) among all the NA genes which were specific vRNA, mRNA, and protein in infected cells. In
order to address the question of whether the codingused in the study (data not shown). It is also possible
that the nonconserved nt are involved in the formation sequences also influence RNA replication, we engi-
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